Takao Kurokawa

Title: Takao Kurokawa: Innovator in Pharmaceutical Adhesive Technologies

Introduction

Takao Kurokawa is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical adhesives, holding a total of 3 patents. His work focuses on developing innovative adhesive patches that enhance drug delivery systems.

Latest Patents

Kurokawa's latest patents include an adhesive patch that comprises an adhesive layer on a backing. This patch contains an adhesive base, a skin irritant drug or a pharmaceutically acceptable salt thereof, and diflucortolone valerate, with the content of diflucortolone valerate ranging from 0.0009 to 0.08% by mass based on the total mass of the adhesive layer. Another significant invention is a rotigotine-containing patch, which features a backing layer and an adhesive agent layer. This layer contains rotigotine and/or a pharmaceutically acceptable salt thereof, along with a styrene-based thermoplastic elastomer, a petroleum-based resin, and a cross-linked polyvinylpyrrolidone. The mass ratio of the rotigotine content to the cross-linked polyvinylpyrrolidone is maintained between 10:3 to 1:3.

Career Highlights

Kurokawa is currently associated with Hisamitsu Pharmaceutical Company, Inc., where he continues to innovate in the field of pharmaceutical adhesives. His work has been instrumental in advancing drug delivery methods, making treatments more effective and accessible.

Collaborations

Throughout his career, Kurokawa has collaborated with notable colleagues, including Hidekazu Kuma and Masaki Yukuhiro. These collaborations have contributed to the successful development of his patented technologies.

Conclusion

Takao Kurokawa's contributions to pharmaceutical adhesive technologies demonstrate his commitment to innovation in the medical field. His patents reflect a deep understanding of drug delivery systems, which can significantly impact patient care.